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Nano-ESI QTOF MS was used for sensitive mapping and sequencing of single molecular
species in complex ganglioside mixtures obtained from human granulocytes, where the
fucosylated carbohydrate chains of granulocyte gangliosides carry sLex and VIM-2 epitopes
postulated to interact with E-selectin of the blood vessel wall in the early phase of the
inflammation process. Functionally relevant components are expressed only at a low level, but
using the negative ion detection it is possible to trace and identify such species, which were not
detectable even by TLC. Advantage of the low-energy CID fragmentation for low abundance
components of the complex ganglioside mixtures in the negative ion mode is to produce
clear-cut series of fragment ions for sequencing. Fucosylation analysis carried out for each
molecular species by MS/MS permits the clear distinction between sLex and VIM-2 epitope.
VIM-2 epitope was expressed in all species with a longer sugar core, while in the short
oligosaccharide chain with a sLex only, using biological material at a mid-femtomol level
detection. (J Am Soc Mass Spectrom 2001, 12, 964–973) © 2001 American Society for Mass
Spectrometry
Gangliosides, sialylated glycosphingolipids(GSLs), are amphiphatic molecules consisting ofa hydrophilic oligosaccharide chain and a hy-
drophobic lipid anchor. To a long chain aminodiol, like
sphingosine (4-sphingenine, d18:1) as a lipid backbone,
fatty acids of different lengths are attached to the amino
group, forming the ceramide moiety. Gangliosides are
postulated to play important roles in modulation of
function of membrane-associated proteins and in cell–
cell recognition phenomena. E-selectin, a carbohydrate-
binding cell adhesion molecule [1], is induced by cyto-
kines such as TNF-a or IL-1b on the surface of
endothelial cells. It mediates the docking of granulo-
cytes to the blood vessel wall and their rolling along the
endothelial cell surface to the loci of inflammation [2]. A
few lines of evidence strongly suggest that certain
fucosylated monosialogangliosides with linear poly-N-
acetyllactosaminyl chains in the plasma membrane of
granulocytes are capable of binding to E-selectin [3–5].
To enhance studies on biological functions of gan-
gliosides [6], main improvements in their purification
[7] and structural analysis [8, 9] have been made. As
recently reported, the hybrid quadrupole time-of-flight
(QTOF) mass spectrometer [10, 11] is a powerful tool for
analysis of complex ganglioside mixtures. In a previous
work, sialylated neolactotetraosyl- and neolacto-
hexaosylceramides (IV3Neu5Ac-nLc4Cer and VI3Neu
5Ac-nLc6Cer, respectively) from human granulocytes
were used as models for fragmentation studies by
nano-electrospray ionization (ESI) tandem mass spec-
trometry (MS/MS) on a QTOF analyzer. Particular
attention was paid toward determination of the sialic
acid moiety attachment site in the type 2 N-acetyllac-
tosamine sugar chain [12]. The aim of the present study
is to explore potentials and limits of nano ESI-QTOF
analysis for detection and full characterization of such
components, which are present in complex ganglioside
mixtures in low amounts, but may play essential roles
in biologically significant interactions. Such ganglio-
sides are the minor components of the described human
granulocyte ganglioside fraction, which contains exclu-
sively terminally a2,3-sialylated monosialogangliosides
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[13]. Determination of fucose attachment sites at penul-
timate, inner core, or proximal GlcNAc moieties in the
poly-N-acetyllactosaminyl chains in the mass range of
m/z 1600 to 3000 was one of the main objectives.
Experimental
Gangliosides from Human Granulocytes
Human leukocytes enriched with granulocytes were
prepared from buffy coats and gangliosides were iso-
lated and purified as previously described [5, 14].
Chloroform and methanol of analytical grade (Merck,
Darmstadt, Germany) were distilled before use. Briefly,
GSLs were extracted with chloroform/methanol (2/1)
and (1/2), each by volume. The combined extracts were
evaporated and partitioned according to Folch et al.
[15]. Gangliosides of Folch upper phases were sepa-
rated from neutral GSLs by anion exchange chromatog-
raphy on diethylaminoethyl (DEAE)-Sepharose CL-6B
(Pharmacia Fine Chemicals, Freiburg, Germany) as re-
ported by Mu¨thing et al. [16]. Total gangliosides were
eluted with 0.45 M ammonium acetate in methanol.
After evaporation and desalting by dialysis, the gangli-
oside fraction was incubated for 1 h at 37 °C in 1 N
NaOH to hydrolyze phospholipids, followed by neu-
tralization with acetic acid and dialysis. Gangliosides
were then further purified by Iatrobeads 6RS-8060 chro-
matography (Macherey-Nagel, Du¨ren, Germany) as de-
scribed by Ueno et al. [17]. Stepwise elution was per-
formed with chloroform/methanol (85/15), (3/1), (2/
1), (1/2), each by volume, and finally methanol. A
neolacto-series ganglioside fraction lacking GM3 spe-
cies was obtained in the chloroform/methanol (1/2)
eluate and was used for preparative high performance
liquid chromatography (HPLC) analysis of gangliosides
as explained in the following section.
High Performance Liquid Chromatography
The separation of a2-3- and a2-6-sialylated monosialo-
gangliosides HPLC was carried out on the Superfor-
mance universal glass cartridge device (Merck, Darm-
stadt) published earlier in detail [5, 13]. A glass
cartridge (150 mm 3 10 mm) filled with Fractogel EMD
TMAE-650(S) (Merck) was loaded with the GM3 de-
pleted ganglioside fraction (chloroform/methanol (1/2)
eluate of the Iatrobeads chromatography, see above).
TMAE-Fractogel bound gangliosides were eluted with
a linear ammonium acetate gradient, pooled, and de-
salted. The pool of ganglioside fractions 16 to 21,
comprising terminally a2-3 sialylated neolacto-type
monosialogangliosides, was used for nano-ESI-QTOF
MS/MS analysis in this study.
Thin-Layer Chromatography
Gangliosides were separated on Silica Gel 60 precoated
high-performance thin-layer chromatography plates
(HPTLC-plates, size 10 cm 3 10 cm, thickness 0.2 mm,
Merck) for 25 min using a mixture of chloroform/
methanol/water (24/17/4, each by vol.) supplemented
with 2 mM CaCl2, and visualized with orcinol [18].
Sample Preparation
The sample containing the complex ganglioside mixture
was dissolved in pure methanol (SupraSolv grade for
organic trace analysis, Merck, Darmstadt, Germany) to
a concentration of approximately 0.03 g/l and sprayed
under optimized conditions with flow rates of approx-
imately 20 nl/min. Acquisition time for the MS spec-
trum was 2 min and 15 to 45 min for acquisition of the
MS/MS spectra. Additionally, comparing experiments
with a bovine brain ganglioside mixture, Cronassial
(Fidia Research Labs, Abano Terme, Italy) were per-
formed, containing 21% GM1a, 40% GD1a, 16% GD1b,
and 19% GT1b, and dissolved in SupraSolv methanol to
a concentration of 0.001 g/l for MS/MS analysis and
1024 g/l for MS mapping.
Mass Spectrometry
The capillaries used for electrospray have been made
in-house from borosilicate glass (Hilgenberg, Malsfeld,
Germany) using a pipette puller (Model 720, David
Kopf Instruments, Tujunga, CA, USA). The high volt-
age is applied via a steel wire to the sample solution as
capillaries are used without further metal coating. Cap-
illary voltages for all experiments were between 1.1 kV
and 1.2 kV. Negative ion mode was used exclusively for
the ganglioside analysis. All experiments were obtained
with a QTOF Mass Spectrometer equipped with a
nanospray manipulator (Micromass, Manchester, UK).
To detect all molecular species as singly charged ions
and to reduce the amount of doubly- and triply charged
molecular ions (to simplify spectra interpretation), the
voltage on the counter electrode was set to 150 V [12].
The voltage at the second orifice leading to the next
pressure stage was set to 4 V, contributing to a signifi-
cant stabilization of the total ion current and therefore
leading to a significantly higher ionization yield. Reso-
lution of investigated signals was measured as full
width at half maximum (FWHM) and was about 5500,
slightly decreasing at the higher mass signals. After
selecting the precursor ion of interest with the first
quadrupole by increasing the DC/AC ratio, collisional
activation was applied to obtain fragment ions for
MS/MS sequencing. The pressure in the collision cell
was approximately 3.8 z 1025 mbar using argon as a
collision gas. The collision energy was set to values,
reducing the intensity of the precursor ion signal to one
third of its original intensity to obtain high fragment ion
abundance within a short period of time. Ions are
guided in a radiofrequency (RF)-only hexapole and
orthogonally extracted to a grid reflector. In all experi-
ments the orthogonal TOF analyzer with time to digital
conversion of the signal detected [19] combined with a
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quadrupole ion guide (hybrid quadrupole-TOF instru-
ment) leads to significant improvement of sensitivity
and resolution. The duty cycle of this instrument,
quoted as 20–22% [20], depends on factors like ratio
between lens opening for orthogonal extraction and the
size of the multichannel plate (MCP) detector, or the
velocity of ions moving into the extraction area between
two voltage pulses.
In general, the nomenclature from Domon and
Costello [21] is used for assignment of fragment ions. To
embrace the observed charge state of fragment ions,
e.g.,Y8/3 ion in the MS/MS spectrum shown in Figure
3a, we applied an (also correct) description, Y8/Y3. The
designation of glycosphingolipids follows the IUPAC-
IUB recommendations [22, 23].
Results and Discussion
The orcinol stain of total gangliosides TLC separation
and a2,3-sialylated monosialogangliosides from human
granulocytes are shown in Figure 1 (lane a and b,
respectively). Human granulocyte gangliosides, e.g.,
IV3Neu5Ac-nLc4Cer or IV6Neu5Ac-nLc4Cer, migrate
differently, giving rise to double bands due to the
substitution of the sphingosine (d18:1) with C24:1 (up-
per band) and C16:0 fatty acid (lower band) [5, 14]. In
this fraction, a2,3-sialylated monosialogangliosides
IV3Neu5Ac-nLc4Cer and VI3Neu5Ac-nLc6Cer (Figure
1, lane b), already structurally characterized, are present
[12]. Minor components of this fraction, which also
migrates as double bands, could possibly be assigned to
fucosylated gangliosides. Deduced from migration be-
haviour in the TLC runs, these low abundance species
could belong to the nLc6Cer or nLc8Cer species with
unknown number and position(s) of fucose moieties.
This mixture was submitted to the nano-ESI QTOF MS
analysis in the negative ion mode, where a ganglioside
map (Figure 2) of this complex mixture was obtained.
Besides the already characterized major components
the low abundance ions were present (marked with an
asterisk). These ions were chosen as precursor ions for
sequencing by MS/MS to investigate if the fragmenta-
tion under low-energy collision-induced dissociation
(CID) conditions can provide the evidence about fuco-
sylation status and discern patterns for assignment of
the fucose attachment to the neolactosyl core. The
presence of two biologically relevant epitopes, differing
in the position of the fucose in the neolacto-type oligo-
saccharide chain (sialyl-Lewisx (sLex) and VIM-2) (Fig-
ure 4b and Figure 5b) have been indicated to be present
in the sample by TLC immunostaining.
The precursor ion at m/z 2246.9 was chosen for
MS/MS sequencing to verify the absence of fucose in
this species. The spectrum (Figure 3a) mainly consists of
Y ions like the Y8 at m/z 1955.9 (loss of sialic acid), Y7 at
m/z 1793.9 (loss of outer galactose) and Y6 at m/z 1590.8
(loss of outer N-acetylglucosamine). The complete se-
quence of the nLc8Cer oligosaccharide chain without
fucose is clearly discerned. All fragments containing a
terminal N-acetylglucosamine (Y7, Y5, Y3) are accompa-
nied by respective Z-ions after neutral loss of water.
Additionally, some B ions like B3 at m/z 655.2 or B4 at
m/z 817.3 are detected at low abundance. Internal frag-
ment ions like Y8/B6 at m/z 1256.4, Y6/B6 at m/z 891.3 or
Figure 1. Orcinol stained thin-layer chromatogram of gangliosides from human granulocytes. Lane
a: 15 mg of total gangliosides; lane b: 5 mg of a2,3-sialylated monosialogangliosides, obtained by
TMAE-Fractogel HPLC, used for structural analysis in this study.
966 METELMANN ET AL. J Am Soc Mass Spectrom 2001, 12, 964–973
Y6/B7 at m/z 729.3 provide additional evidence for the
core chain with alternating Gal and GlcNAc units, a
terminal neuraminic acid and a d18:1/16:0-ceramide
(Figure 3b), confirming the TLC immunostaining
results. The nLc8Cer molecular ion with a C24:1 fatty
acid in the ceramide part at m/z 2357.0 is barely
detectable in the mapping spectrum (Figure 2, zoomed
part). Although it was possible to carry out MS/MS
analysis (spectrum not shown) and the product ions
were obtained at much lower s/n ratio than for the
d18:1/16:0 species: only the high abundance signals,
such as the Y4 ion at m/z 1335.8 or the Y8 at m/z 2065.9
(loss of sialic acid), gave evidence of the proposed
structure.
In the MS/MS spectrum of the low abundance
precursor ion at m/z 1662.9 (Figure 4a), Y-type ions like
the Y3b ion at m/z 1516.9 (loss of fucose) provide a direct
hint for its fucosylation status via a relationship to the
non-fucosylated structure of the molecular species at
m/z 1517.0 (IV3Neu5Ac-nLc4) in Figure 2. The Y4a ion at
m/z 1371.8 (loss of sialic acid) or the abundant Y2 ion at
m/z 860.7 are produced as well as a number of internal
fragments (e.g., Y4a/B3 at m/z 510.2, Y3b/B3 at m/z 655.2,
or Y3a/Y3b at m/z 1063.7) supporting this relationship.
Besides, the ion at m/z 680.6 corresponding formally to
the Z1 ion, rarely detected in the native ganglioside
low-energy CID MS/MS, was present. The Y3a ion at
m/z 1209.8, presented in the frame, is of diagnostic
relevance for determination of the fucose attachment
site. Sialic acid and one galactose are cleaved off but the
fucose is still present, suggesting attachment to the
N-acetylglucosamine which would be in agreement
with the immunostaining results. The corresponding
characteristic tetrasaccharide B3 ion (sequence: Neu5Ac-
Gal-GlcNAc) was not detected, but deduced from the
number of N-acetylglucosamine residues in the oligo-
saccharide chain, the epitope structure of sLex (Figure
4b) is the single feasible structure.
In the higher mass range, the ion at m/z 2138.0 was
selected for fragmentation related to fucosylation status
(Figure 5a). In its MS/MS spectrum a complete series of
Y ions was detected starting with the Y3b at m/z 1991.9
(loss of fucose) characteristic for the core of the sialy-
lated nLc6-(d18:1/24:1) structure. The Y6a ion at m/z
1846.9 (loss of sialic acid) and the cleavage at each of the
following sugar units is observed: Y5a at m/z 1684.8, Y4a
at m/z 1481.8. The ceramide ion Y0 at m/z 646.6 is
indicative for the presence of a C24:1 fatty acid linked to
the sphingoid base. In this MS/MS spectrum both
characteristic ions for the attachment of the fucose
moiety were found: Y3a ion at m/z 1319.8 and the
corresponding B5 ion at m/z 1166.4, providing evidence
for the VIM-2 structural epitope (Figure 5b). The high
abundance signal at m/z 1335.8 (Y4a/Y3b) could arise
Figure 2. MS spectrum of the investigated ganglioside mixture. Only the region of molecular ions is
presented. Signals marked with an asterisk were investigated in detail.
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from the loss of a sLex structural epitope at the nonre-
ducing terminus of the carbohydrate chain as well as
from a loss of Neu5Ac-Gal-GlcNAc trisaccharide be-
sides an additional, unspecific loss of fucose from
another position in the chain. The latter assumption is
supported by the presence of fucosylated fragment ions
at lower m/z than the observed Y4a/Y3b and by the
corresponding B3a ion at m/z 655.2 without fucose. A
conclusion based on this evidence is supportive for the
VIM-2 epitope structure at the nonreducing end.
The structural relationship of the ions at m/z 2138.0
and m/z 2027.9 (data not shown) is clearly deducible
from values of their respective molecular masses and
Y-fragment ions, differing by 110.1 Da from those
shown in Figure 5a. This feature is typical for compo-
nents with identical carbohydrate chain but different
fatty acids in the ceramide part (see also Figure 1). Due
to the presence of two Y ions: Y4a/Y3b at m/z 1225.7 and
Y3a at m/z 1209.7, a distinction between sLe
x and VIM-2
structure would be difficult. Using the evidence from
the corresponding B-ions, the distinction between these
two epitopes is, however, possible, deduced from the
presence of the VIM-2 characteristic B5 ion at m/z 1166.4
at low abundance and from the absence of the fucosy-
lated B3a ion characteristic for sLe
x.
The series of Y fragment ions in the MS/MS spec-
trum of the precursor ion at m/z 2503.3 (Figure 6a)
diagnostic for the sialylated nLc8 family, was accompa-
nied by the Y0 ion at m/z 646.6, commonly observed for
a (d18:1/24:1) ceramide. After loss of sialic acid result-
ing in Y8a ion at m/z 2212.6 an alternating stepwise loss
of galactose and N-acetylglucosamine was documented
by Y7a ion at m/z 2050.5, Y6a ion at m/z 1847.2, Y5a ion at
m/z 1685.1, Y4 ion at m/z 1336.0, Y3 ion at m/z 1173.9, Y2
ion at m/z 970.7. The Y5a ion (framed) at m/z 1685.1 and
the B5 ion at m/z 1166.4 (framed, zoomed part in Figure
6a) support the evidence for the VIM-2 structural
epitope (Figure 6b). It should be mentioned that the
Figure 3. (a) MS/MS spectrum of the ion at m/z 2246.9 as a precursor. All fragment ions appear as
singly charged species. (b) Proposed molecular structure of the molecular species characterized by the
ion at m/z 2246.9. R is a fatty acid residue with either a C16:0 or a C24:1 chain.
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Y6a/Y5b ion at m/z 1701.2 could arise either from a loss
of a sLex epitope or from a loss of Neu5Ac-Gal-GlcNAc
besides an additional, unspecific loss of fucose from
another position in the chain. A sLex characteristic B3a
ion (calculated m/z 801.3) was not detected, contrary to
the nonfucosylated B3a at m/z 655.3.
The MS/MS spectrum of the ion at m/z 2393.1 (not
shown), reveals the structural relationship of the mo-
lecular ions at m/z 2503.3 and m/z 2393.1. In the com-
parison of the Y-ion series, mass differences depict
the same structural homology as mentioned before
with the ion pair at m/z 2138.0 and m/z 2027.9, where
each observed fragment ion has its counterpart in the
spectrum shown in Figure 6a but differs by 110.1 Da.
A number of homologous inner fragments like Y6a/B7
at m/z 875.4, Y5a/B9 at m/z 1037.5, or Y6a/B7/Y5b at
m/z 729.3 support this fact. In the carbohydrate moi-
ety, common for both precursor ions, particular at-
tention was directed toward two Y ions, Y6a/Y5b at
m/z 1590.9 and Y5a at m/z 1574.9, present in the
spectra. Because the fucosylated B3a ion that would
have been characteristic for sLex was not detected,
and the B5 ion was observed at m/z 1166.4 (VIM-2)
with only low abundance, the distinction between
sLex and VIM-2 structures could not confidently be
made.
Figure 4. (a) MS/MS spectrum of the molecular ion at m/z 1662.9 as a precursor. All fragment ions
appear as singly charged species. (b) Proposed molecular structure of the molecular species
characterized by the ion at m/z 1662.9.
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Figure 5. (a) MS/MS spectrum of the molecular ion at m/z 2138.0 as a precursor. All fragment ions
appear as singly charged species. (b) Proposed molecular structure of molecular species characterized
by ions at m/z 2027.9 and m/z 2138.0. R is a fatty acid residue with either a C16:0 or a C24:1 chain.
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Sample Consumption and Detection Limit
The nanospray flowrate of 20 nl min21 was calculated
in experiments using methanol as a solvent and the
laboratory made capillaries, from which it was possible
to detect ions for at least one hour. The overall con-
sumption for the particular experiment was estimated
after measuring the volume of the retained liquid,
where the values obtained had a deviation of about
650%, because of the scattering quality of the spray
capillaries, as was observed by others also [24].
For a short MS, 2 min acquisition time and 40 nl of
the ganglioside mixture were required. The overall
sample consumption for MS/MS was calculated to be in
a range between 3 pmol (ion at m/z 2138.0) and 16 pmol
(ion at m/z 1662.9), depending on different acquisition
times (15 to 45 min). These relatively high amounts are
a concession to the importance of low abundance sig-
nals in the product ion spectra which would allow
distinction between different biological epitopes and
would probably not be detectable at lower sample
concentration.
To demonstrate that the QTOF sensitivity for glyco-
sphingolipids can reach even a femtomol or subfemto-
mol range, a MS spectrum was acquired from the
Cronassial standard ganglioside mixture, where a clear
detection of each predicted ganglioside species and
their respective ions [M2H]2 could be achieved after
1.25 min acquisition time (25 nl). The sample consump-
tion for a single molecular ganglioside species in MS
should be considered as a relative amount of each
molecular species. For GM1a species it was calculated
to be 340 amol, for GD1a and GD1b species 751 amol,
and for GT1b species 215 amol. Clear fragmentation
spectra by MS/MS with a s/n ratio 4:1 even for low
Figure 6. (a) MS/MS spectrum of the molecular ion at m/z 2503.3 as a precursor. All fragment ions
appear as singly charged species. (b) Proposed molecular structure of molecular species characterized
by ions at m/z 2393.1 and m/z 2503.3. R is a fatty acid residue with either a C16:0 or a C24:1 chain.
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abundance signals were obtained within 2 min for
GM1a and 50 min acquisition time for GT1b, which
makes a consumption of 0.55 fmol of GM1a and 8.6 fmol
of GT1b. These values, however, theoretically include
the natural distribution of different fatty acids attached
to the sphingosine so that the real amount of material
for one isolated molecular ion is even lower.
It is important to mention that the relative abun-
dance of single ion species in the MS spectrum of the
Cronassial mixture cannot be directly correlated with
values for the relative amount of the gangliosides
obtained probably from densitometrical measurements
from TLC plates: although GM1a is only contained with
21%, it shows the most abundance signals in the nega-
tive ion mode spectrum (approximately 82%).
Conclusions
Using ESI MS and low-energy CID MS/MS a complex
ganglioside mixture was analyzed on the QTOF instru-
ment to trace and identify components, which may play
a significant role in cell adhesion. It was possible to
demonstrate the feasibility of detection and sequencing
of gangliosides, which are present at low abundance,
using negative ion detection mode. The position of the
fucose attachment was determined for each molecular
species. MS/MS spectra interpretation permits the clear
distinction between sLex and VIM-2 epitope structures
even if only low abundance fragment ions are present,
due to the high dynamic range of the instrument. It can
be postulated that the VIM-2 epitope is expressed in all
species with a longer sugar core, as in nLc6 and nLc8,
while in the short oligosaccharide chain of nLc4
whithout the possibility of VIM-2 formation a sLex
epitope only is expressed. Seven low abundance molec-
ular species, investigated and structurally characterized
in this study are listed in Table 1. Using this approach a
fucosylated IV3Neu5Ac-nLc4 species not detected in the
TLC chromatogram (Figure 1) was structurally charac-
terized demonstrating the sensitivity of this experiment.
Furthermore, two nonfucosylated species of VIII3Neu5Ac-
nLc8 with molecular ions at m/z 2246.9 and m/z 2357.0
(Figure 2) were identified. The MS/MS data supported the
original hypothesis that the TLC bands can be assigned to
the fucosylated VI3Neu5Ac-nLc6-Cer and VIII3Neu5Ac-
nLc8-Cer species, with two different fatty acids in the
ceramide.
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